On May 12, 2025, Biogen Inc. completed the issuance and sale of $1.75 billion aggregate principal amount of senior unsecured notes. The offering consisted of $400 million of 5.050% Senior Notes due 2031, $650 million of 5.750% Senior Notes due 2035, and $700 million of 6.450% Senior Notes due 2055. This follows the company's entry into an underwriting agreement on May 6, 2025, with BofA Securities, Inc., Citigroup Global Markets Inc., and J.P. Morgan Securities LLC. The net proceeds from this offering, combined with cash on hand, will be used to fully retire Biogen's outstanding 4.050% Senior Notes due 2025, which had an outstanding amount of $1.75 billion as of March 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-117854), on May 12, 2025, and is solely responsible for the information contained therein.